semaglutide shortage november 2025 news Yearslong of popular weight-loss and diabetes drugs is resolved, FDA says Semaglutide shortage ends as FDA

Ensuring Healthy Weight Loss The researchers ultimately conclude that GLP-1 drugs significantly reduce body weight and adiposity, along with a substantial FFM [fat-free mass] loss, but with no clear evidence of CRF enhancement. They remain concerned that this could take a toll on patients metabolic health, healthspan/frailty and overall longevity

Improved tolerability for sensitive individuals

Drugs such as retatrutide can certainly assist, but the majority of individuals will still need to implement dietary, exercise, and behavioral modifications

Preparing an auto-injector If youre using a pen delivery system for a subcutaneous injection, filling it with medication is slightly different from filling a syringe